• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异性膜抗原- HBED-CC 正电子发射断层扫描/计算机断层扫描示明显摄取的韧带样纤维瘤。

Desmoid Tumor Showing Intense Uptake on 68Ga PSMA-HBED-CC PET/CT.

机构信息

From the Departments of *Nuclear Medicine and †Radiation Oncology, Royal North Shore Hospital, Sydney, Australia.

出版信息

Clin Nucl Med. 2016 Jun;41(6):508-9. doi: 10.1097/RLU.0000000000001192.

DOI:10.1097/RLU.0000000000001192
PMID:26909712
Abstract

Ga-PSMA PET/CT is a new imaging technique that is highly sensitive to metastatic prostate cancer lesions compared with other conventional imaging modalities. We report a case of a 77-year-old man with newly diagnosed prostate carcinoma who had a PSMA PET/CT scan for staging of his disease. An intensely PSMA-avid right pelvic mass was identified abutting the cecum and terminal ileum. Surgical removal and histopathologic examination of this lesion revealed the diagnosis of a desmoid tumor. It is important to be aware that many tumors other than prostate carcinoma may also show avid uptake on PSMA PET/CT scan.

摘要

镓-PSMA PET/CT 是一种新的成像技术,与其他常规成像方式相比,对转移性前列腺癌病变具有更高的敏感性。我们报告了一例 77 岁男性新诊断的前列腺癌患者,他进行 PSMA PET/CT 扫描以分期他的疾病。在 PSMA 上发现一个强烈摄取的右侧骨盆肿块,紧贴盲肠和末端回肠。对该病变进行手术切除和组织病理学检查,结果显示为硬纤维瘤的诊断。需要注意的是,许多除前列腺癌以外的肿瘤也可能在 PSMA PET/CT 扫描上显示摄取增加。

相似文献

1
Desmoid Tumor Showing Intense Uptake on 68Ga PSMA-HBED-CC PET/CT.前列腺特异性膜抗原- HBED-CC 正电子发射断层扫描/计算机断层扫描示明显摄取的韧带样纤维瘤。
Clin Nucl Med. 2016 Jun;41(6):508-9. doi: 10.1097/RLU.0000000000001192.
2
Schwannoma Showing Avid Uptake on 68Ga-PSMA-HBED-CC PET/CT.神经鞘瘤在 68Ga-PSMA-HBED-CC PET/CT 上呈明显摄取。
Clin Nucl Med. 2016 Sep;41(9):703-4. doi: 10.1097/RLU.0000000000001281.
3
Follicular Lymphoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT.滤泡性淋巴瘤在 68Ga PSMA-HBED-CC PET/CT 上呈强烈摄取。
Clin Nucl Med. 2016 Jun;41(6):500-1. doi: 10.1097/RLU.0000000000001169.
4
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
5
Follicular Thyroid Adenoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT.滤泡性甲状腺腺瘤在68Ga PSMA-HBED-CC PET/CT上显示出高摄取。
Clin Nucl Med. 2016 Apr;41(4):331-2. doi: 10.1097/RLU.0000000000001084.
6
Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.双相⁶⁸Ga-PSMA-HBED-CC-PET/CT在复发性和高危前列腺癌患者中的应用
Eur J Nucl Med Mol Imaging. 2016 May;43(5):898-905. doi: 10.1007/s00259-015-3251-y. Epub 2015 Nov 12.
7
68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.68Ga-PSMA-11 PET/CT 衍生的定量肿瘤体积参数可用于前列腺癌骨转移患者的分类和治疗反应评估。
Ann Nucl Med. 2019 Oct;33(10):766-775. doi: 10.1007/s12149-019-01387-0. Epub 2019 Jul 23.
8
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.复发前列腺癌患者中[(18)F]DCFPyL与[(68)Ga]Ga-PSMA-HBED-CC用于PSMA-PET成像的比较
Mol Imaging Biol. 2015 Aug;17(4):575-84. doi: 10.1007/s11307-015-0866-0.
9
68Ga-PSMA-HBED-CC-Avid Synchronous Urinary Bladder Paraganglioma in a Patient With Metastatic Prostate Carcinoma.68Ga-PSMA-HBED-CC 放射性配体靶向药物诊断同步发生于转移性前列腺癌患者的膀胱副神经节瘤。
Clin Nucl Med. 2018 Sep;43(9):e329-e330. doi: 10.1097/RLU.0000000000002172.
10
Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT.使用 68Ga-HBED-CC-PSMA PET/CT 对转移性分化型甲状腺癌中前列腺特异性膜抗原表达进行成像。
Clin Nucl Med. 2017 Jan;42(1):20-25. doi: 10.1097/RLU.0000000000001454.

引用本文的文献

1
Annotating the Role of F-FDG PET/CT in Fibromatoses: A Benign Masquerader of Malignancies-Is It Really an Advantageous Tool?阐述F-FDG PET/CT在纤维瘤病中的作用:恶性肿瘤的良性伪装者——它真的是一种有用的工具吗?
Nucl Med Mol Imaging. 2024 May;58(3):140-146. doi: 10.1007/s13139-024-00846-5. Epub 2024 Feb 14.
2
Head-to-head comparison of [Ga]Ga-PSMA-11 and [F]FDG PET/CT in multiple myeloma.镓[68Ga]PSMA-11 与氟[18F]脱氧葡萄糖 PET/CT 对头对头比较多发性骨髓瘤。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2432-2440. doi: 10.1007/s00259-023-06214-3. Epub 2023 Mar 29.
3
False Positive Findings of [F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels.
血清PSA水平不可测的前列腺癌根治术后患者中[F]PSMA - 1007 PET/CT的假阳性结果
Front Surg. 2022 Jun 24;9:943760. doi: 10.3389/fsurg.2022.943760. eCollection 2022.
4
[Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.[镓]镓-PSMA-11在前列腺癌中的应用:综述
Am J Nucl Med Mol Imaging. 2020 Dec 15;10(6):349-374. eCollection 2020.
5
Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.寻找错误地方的药物:GCPII 抑制剂在大脑外的应用。
Neurochem Res. 2020 Jun;45(6):1256-1267. doi: 10.1007/s11064-019-02909-y. Epub 2019 Nov 20.
6
Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT.用于治疗诊断放射性示踪剂的分子影像报告和数据系统(MI-RADS)的最新进展——应对生长抑素受体(SSTR)和前列腺特异性膜抗原(PSMA)靶向PET/CT的陷阱
J Clin Med. 2019 Jul 19;8(7):1060. doi: 10.3390/jcm8071060.
7
Nonspecific Uptake of Ga-Prostate-Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature.正电子发射断层扫描/计算机断层扫描成像中,镓标记前列腺特异性膜抗原在前列腺恶性肿瘤以外疾病中的非特异性摄取:影像学分析及文献综述
Indian J Nucl Med. 2018 Oct-Dec;33(4):317-325. doi: 10.4103/ijnm.IJNM_81_18.
8
68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.68Ga-PSMA PET/CT 在前列腺癌患者中的应用——疾病的表现形式、良性发现和误区。
Cancer Imaging. 2018 Nov 1;18(1):39. doi: 10.1186/s40644-018-0175-3.
9
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications.分子影像报告与数据系统(MI-RADS):具有治疗诊断意义的靶向放射性示踪剂的通用框架。
Ann Nucl Med. 2018 Oct;32(8):512-522. doi: 10.1007/s12149-018-1291-7. Epub 2018 Aug 14.
10
Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.放射性配体靶向 PSMA 在非前列腺疾病中的应用:现状与未来展望。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):860-877. doi: 10.1007/s00259-017-3922-y. Epub 2018 Jan 15.